Inhibition of hepatic gluconeogenesis by 4-pentenoic acid.
D000409:Alanine / Q000378:metabolism; D000818:Animals; D002210:Caprylates / Q000494:pharmacology; D003065:Coenzyme A / Q000378:metabolism; D003864:Depression, Chemical; D005227:Fatty Acids / Q000494:pharmacology*; D005943:Gluconeogenesis / Q000187:drug effects*; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D007657:Ketone Bodies / Q000096:biosynthesis; D007773:Lactates / Q000378:metabolism; D008025:Ligases / Q000037:antagonists & inhibitors; D008041:Linoleic Acids / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D010477:Perfusion; D011773:Pyruvates / Q000378:metabolism; D051381:Rats
D002210:Caprylates; D005227:Fatty Acids; D007657:Ketone Bodies; D007773:Lactates; D008041:Linoleic Acids; D011773:Pyruvates; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D008025:Ligases; D000409:Alanine; D003065:Coenzyme A